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Abstract 
 Silver sulfadiazine is a topical medicine that belongs to sulfa antibiotics class of drugs and used in treating 
wound infections in burn patients. The aim of this study was to determine the effect of Consciousness Energy 
Healing Treatment (the Trivedi Effect®) on the various properties of silver sulfadiazine with the help of modern 
analytical techniques. The sample was divided into two parts; the first part was not given any treatment and 
considered as a control sample, while the second part was provided the Consciousness Energy Healing Treatment 
by the Biofield Energy Healer, Gopal Nayak remotely, named as the treated sample. The powder XRD data 
showed significant alterations in the peak intensities of the treated sample ranging from-30.71% to 47.54% 
compared to the control sample. The crystallite size was altered ranging from -78.12% to 1.47%; and the average 
crystallite size was significantly reduced by 31.62% in the treated sample compared to the control sample. The 
particle sizes were decreased in the treated sample by 12.75%(d10), 4.98%(d50), 0.89%(d90), and 2.92%{D(4,3)}; 
thus, the specific surface area was significantly increased by 17.31% compared with the control sample. The 
latent heat of fusion and latent heat of decomposition were profoundly increased by 24.62% and 156.28%, 
respectively in the treated sample compared to the control sample. The total weight loss was increased by 3.08% 
and the residue amount was reduced by 4.44% in the treated sample compared to the control sample. Thus, the 
Trivedi Effect®-Consciousness Energy Healing Treated sample might form a new polymorph of silver sulfadiazine 
that possesses reduced particle size and improved thermal properties compared to the untreated sample. 
Therefore, the Biofield Energy treated sample can be used in nutraceutical/pharmaceutical formulation, which 
would show a better bioavailability and therapeutic response against various infections in comparison to the 
control sample. 
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Introduction 
 Silver sulfadiazine is a topical medicine that 
belongs to sulfa- antibiotics class of drugs. It is used as 
an adjuvant in treating and preventing wound infections 
in burn patients. Silver sulfadiazine works on the 
bacteria by stopping their growth on the open wound; 
thereby decrease the risk of their spreading to the 
surrounding skin or to the blood where they may cause 
sepsis [1]. Silver ions are considered as a biocide that 
has the ability to binds to a broad range of targets. Such 
targets include the nucleophilic amino acids, amino, 
sulfhydryl, phosphate, imidazole, and carboxyl groups 
present in the proteins. Moreover, the binding to such 
sites of proteins causes enzyme inhibition by the process 
of protein denaturation [2]. Also, silver binds to the 
proteins present on the surface membranes and thus 
causes proton leaks in the membrane, which ultimately 
leads to the death of the cell. Besides, sulfadiazine 
works as a competitive inhibitor of bacterial para-
aminobenzoic acid (PABA), which inhibited the reaction 
that is vital in the folic acid synthesis [3,4]. Although 
silver sulfadiazine is used topically; however, it is poorly 
soluble and has limited penetration through intact skin 
[5]. In recent days, the studies have been done on the                 
physicochemical properties of the drug that mainly 
impart their effect on the absorption and bioavailability 
parameters of the formulation [6]. Thus, this study was 
also done with emphasizing the techniques that may 
improve these parameters of silver sulfadiazine.  
 The Biofield Energy Healing Treatment                    
(the Trivedi Effect®) has been considered these days as 
a novel approach due to its considerable impact on the 
physicochemical and thermal behaviour of various 
compounds [7-9]. The Trivedi Effect® is considered as a 
scientifically proven phenomenon which involves the 
principle that a person can harness the inherently 
intelligent energy from its surroundings and transmit it 
in an object(s) (living/non-living) through the possible 
mediation of neutrinos [10]. This kind of energy is 
known as Biofield Energy that is possessed by every 
living organism surrounding the body, and it is infinite 
and para-dimensional electromagnetic field. The Biofield 
Energy (Putative Energy Fields) based Healing Therapies 
have been reported by various studies due to their 
significant outcomes against various medical                 
conditions [11]. Therefore, the National Institutes of 
Health (NIH) and the National Center for                       
Complementary and Alternative Medicine (NCCAM) 
included such Energy therapies under the category of 
Complementary and Alternative Medicine (CAM) and is 
accepted by the most of the U.S. population [12,13]. 
 The Trivedi Effect®-Consciousness Energy 
Healing Treatment has also been known for its ability to 
alter the characteristic properties of the organic 
compounds [14-16], metals and ceramic [17,18], 
nutraceuticals/pharmaceuticals [19,20], and in the field 
of microbiology [21-23], skin health [24,25], 
biotechnology [26,27], bone health [28-30], cancer 
science research [31,32], and crops [33,34]. Hence, the 
current study was designed with the aim to analyze the 
effect of the Trivedi Effect®-Consciousness Energy 
Healing Treatment on the physicochemical and thermal 
properties of silver sulfadiazine using modern analytical 
techniques. 
Materials and Methods 
Chemicals and Reagents 
 Silver sulfadiazine was purchased from Tokyo 
Chemical Industry Co., Ltd., Japan. All other chemicals 
used during the experiments were of analytical grade 
available in India.  
Consciousness Energy Healing Treatment Strategies 
 The study involved dividing the silver 
sulfadiazine test sample into two parts. The first part 
was considered as a control sample and no Biofield 
Energy Treatment was given to it. Besides, the second 
part of the sample was treated with the Trivedi                       
Effect®-Energy of Consciousness Healing Treatment by 
the renowned Biofield Energy Healer, Gopal Nayak, 
India, remotely under standard laboratory conditions for 
3 minutes and known as the Biofield Energy Treated 
sample. Later, the control sample was treated with a 
“sham” healer (did not have any knowledge about the 
Biofield Energy Treatment) for comparison purpose. 
Consequently, the control and Biofield Energy Treated 
samples were kept in sealed conditions and      
characterized using modern analytical techniques.  
Characterization 
 The powder X-ray diffraction (PXRD), particle 
size analysis (PSA), thermogravimetric analysis (TGA)/
differential thermogravimetric analysis (DTG), and 
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differential scanning calorimetry (DSC) analysis of silver 
sulfadiazine were performed. The powder XRD analysis 
of silver sulfadiazine powder sample was performed with 
the help of Rigaku MiniFlex-II Desktop X-ray 
diffractometer (Japan) [35, 36]. The average size of 
crystallites was calculated from powder XRD data using 
the Scherrer’s formula (1)  
G = kλ/βcosθ (1) 
 Where G is the crystallite size in nm, k is the 
equipment constant (0.94), λ is the radiation wavelength 
(0.154056 nm for Kα1 emission), β is the full-width at 
half maximum, and θ is the Bragg angle [37].  
 The PSA was performed using Malvern 
Mastersizer 2000, from the UK with a detection range 
between 0.01 µm to 3000 µm using the wet method. 
Similarly, the DSC analysis of silver sulfadiazine was 
performed with the help of DSC Q200, TA Instruments.  
The TGA/DTG thermograms of silver sulfadiazine were 
obtained with the help of TGA Q50 TA                   
instruments [38,39].  
 The % change in particle size, specific surface 
area (SSA), peak intensity, crystallite size, melting point, 
latent heat, weight loss and the maximum thermal 
degradation temperature (Tmax) of the Biofield Energy 
Treated sample was calculated compared with the 
control sample using the following equation 2: 
     (2) 
Results and Discussion 
Powder X-ray Diffraction (PXRD) Analysis  
 The Biofield Energy Treated sample showed 
sharp and intense peaks in its diffractogram that are 
similar to the diffractogram of the control sample, 
representing the crystalline nature of both the samples. 
However, the Bragg’s angles (2q) of these peaks of the 
treated sample were observed to differ from the Bragg’s 
angles of the peaks of the control sample (Figure 1) in 
the PXRD diffractogram. The highest peak intensity in 
the diffractograms of the control and the treated sample 
was present at 2θ equal to 10.08° and 10.37º, 
respectively (Table 1, entry 2). Besides, the intensities of 
the peaks of the Biofield Energy Treated sample were 
found to be significantly altered ranging from -30.71% 
to 47.54% in comparison to the control sample. Also, 
the crystallite sizes of the treated silver sulfadiazine 
sample were observed to be altered significantly 
compared to the control sample. The significant 
decrease in crystallite size was observed for most of the 
peaks ranging from 2.34% to 78.12%; however the 
crystallite size at position 2θ equals to 20.69º was 
slightly increased by 1.47% (Table 1, entry 7), as 
compared to the control sample. The average crystallite 
size of the treated silver sulfadiazine sample                       
(307.36 nm) was also decreased by 31.62% in 
comparison to the control sample (449.50 nm). 
  It is studied in various researches that 
the peak intensity of each diffraction face varied based 
on the alteration in the crystal morphology of the 
crystalline compound [40]. Such changes in the 
intensities of the peak and the corresponding alterations 
in the crystallite sizes of the treated sample indicate that 
the crystal morphology might be affected due to the 
Biofield Energy Treatment, compared to the untreated 
sample. Also, the changes in the PXRD pattern denote 
polymorphic transitions taken place in the compound 
[41,42]. Various scientific studies confirm the impact of 
different polymorphic forms of any drug on its 
therapeutic efficacy, bioavailability, and toxicity [43, 44]. 
Thus, the Trivedi Effect® Treated sample might be 
considered to form a new polymorphic form of silver 
sulfadiazine that may offer better performance when 
used in the pharmaceutical formulations in comparison 
to the untreated sample. 
Particle Size Analysis (PSA) 
 The control and Biofield Energy Treated sample 
were analysed for their particle size distribution and the 
results were presented in Table 2. The control silver 
sulfadiazine showed particle size distribution at d10, d50, 
d90, and D(4,3) as 7.92 µm, 30.09 µm, 93.61 µm,                   
and 43.51 µm, respectively. On the other hand, the 
particle size values of the treated sample were observed 
as 6.91 µm, 30.49 µm, 92.78 µm, and 42.24 µm at d10, 
d50, d90, and D(4,3), respectively. Hence, the Biofield 
Energy Treated sample showed a decrease in particle 
size values by 12.75%, 4.98%, 0.89%, and 2.92% at 
d10, d50, d90, and D(4,3), respectively compared to the 
control silver sulfadiazine sample. The reduction in 
particle sizes resulted in a significant increase in the 
specific surface area of the treated sample (0.61m2/g) 
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Table 1. PXRD data for the control and Biofield Energy Treated silver sulfadiazine. 
Entry 
No. 
  Bragg angle (°2θ)          Peak Intensity (%)           Crystallite size (G, nm) 
Control Treated Control Treated % change a Control Treated % change b 
1 8.67 8.91 241 167 -30.71 564 272 -51.77 
2 10.08 10.37 1059 968 -8.59 536 304 -43.28 
3 12.83 13.16 57 51 -10.53 522 350 -32.95 
4 15.97 16.23 63 61 -3.17 474 345 -27.22 
5 18.34 18.61 150 171 14.00 621 399 -35.75 
6 19.73 19.94 76 75 -1.32 348 310 -10.92 
7 20.53 20.69 64 65 1.56 272 276 1.47 
8 21.38 21.68 55 49 -10.91 478 353 -26.15 
9 22.95 23.20 83 89 7.23 463 362 -21.81 
10 24.16 24.39 113 118 4.42 368 327 -11.14 
11 27.77 27.99 138 132 -4.35 175 167 -4.57 
12 33.05 33.27 97 87 -10.31 385 376 -2.34 
13 37.25 37.52 61 90 47.54 681 149 -78.12 
14 38.29 38.58 86 75 -12.79 406 313 -22.91 adenotes the percentage change in the intensity of Biofield Energy Treated sample with respect to the                  
control sample;  
bdenotes the percentage change in the crystallite size of Biofield Energy Treated sample with respect to the 
control sample. 
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Figure 1. PXRD diffractograms of the control and Biofield Energy Treated silver sulfadiazine. 
Parameter d10 (µm) d50 (µm) d90 (µm) D(4,3)(µm) SSA(m
2/g) 
Control 7.92 32.09 93.61 43.51 0.52 
Biofield Treated 6.91 30.49 92.78 42.24 0.61 
Percent change* (%) -12.75 -4.98 -0.89 -2.92 17.31 
Table 2. Particle size distribution of the control and Biofield Energy Treated silver sulfadiazine. 
d10, d50, and d90: particle diameter corresponding to 10%, 50%, and 90% of the cumulative distribution, D
(4,3): the average mass-volume diameter, and SSA: the specific surface area. *denotes the percentage 
change in the Particle size distribution of the Biofield Energy Treated sample with respect to the control 
sample. 
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by 17.31% as compared with the control sample 
(0.52m2/g). Thus, it could be presumed that the Trivedi                                    
Effect® -Consciousness Energy Healing Treatment might 
help in reducing the particle size of the treated sample 
by acting like an external force [45]. Besides, it is 
established in various studies that the reduced particle 
size ensures increased surface area that ultimately helps 
to improve the bioavailability of the drug [46-48]. 
Hence, the Biofield Energy Treated silver sulfadiazine 
might offer improved absorption and in comparison to 
the untreated sample.  
Differential Scanning Calorimetry (DSC) Analysis  
 The DSC analysis of the control and Biofield 
Energy Treated sample has been done (Table 3 and 
Figure 2) for characterizing the thermal behavior of both 
the samples. The DSC thermograms of both the samples 
showed two peaks among which, one was endothermic 
while the other was exothermic in nature. The 
thermograms of the control and treated sample showed 
the sharp endothermic peak at 262.90°C and 262.55°C, 
respectively that is considered as their melting point 
(Figure 2). The further analysis revealed a slight 
decrease in the melting point of the treated sample by 
0.13% in comparison to the control sample (Table 3).  
  However, the latent heat of fusion 
(∆Hfusion) of the treated silver sulfadiazine was found to 
be significantly increased by 24.62% compared with the 
control sample (Table 3). Besides, the exothermic peak 
observed in the thermograms of both the samples 
represents the decomposition temperature of silver 
sulfadiazine. Although, the decomposition temperature 
of the Biofield Energy Treated sample was slightly 
decreased by 1.65%, however, the corresponding ∆H 
was significantly increased by 156.28% that could be 
due to the disruption in the molecular chains present in 
the crystal structure [45]. Hence, it is presumed that the 
Biofield Energy Treatment might disrupt the crystal 
structure of silver sulfadiazine that ultimately resulted in 
the decreased melting point of the Biofield Energy 
Treated sample in comparison to the control sample. 
Thermal Gravimetric Analysis (TGA)/ Differential 
Thermogravimetric Analysis (DTG) 
 The TGA thermograms of the control and 
Biofield Energy Treated samples are shown in Figure 3 
and the data were presented in Table 4. The data 
reported the increase in the total weight loss of the 
treated sample by 3.08% and the residue amount was 
decreased by 4.44% compared with the control sample 
(Table 4). 
 The DTG thermograms of both, the control and 
the treated silver sulfadiazine sample showed only one 
peak (Figure 4). The Tmax of the control sample was 
observed at 281.80°C, while the treated sample showed 
it at 277.10°C. Thus, the Biofield Energy Treated sample 
showed a slight reduction in the Tmax by 1.67% as 
compared with the control sample (Table 4). Overall, 
TGA/DTG revealed that the thermal stability of the 
Biofield Energy Treated silver sulfadiazine was altered 
compared with the control sample that might occur due 
to the reduction in the particle size of the sample [49]. 
Conclusions 
 The Trivedi Effect®-Consciousness Energy 
Healing Treatment has a profound impact on various 
physicochemical and thermal properties of silver 
sulfadiazine. The powder XRD data showed significant 
alterations in the peak intensities of the Biofield Energy 
Treated sample ranging from -30.71% to 47.54% 
compared to the control sample. The crystallite size was 
altered ranging from -78.12% to 1.47%; and the 
average crystallite size was significantly reduced by 
31.62% in the Biofield Energy Treated sample compared 
to the control sample. The particle sizes were decreased 
in the Biofield Energy Treated sample by 12.75%(d10), 
4.98%(d50), 0.89%(d90), and 2.92%{D(4,3)}; thus, the 
specific surface area was significantly increased by 
17.31% compared with the control sample. The ∆Hfusion 
and ∆Hdecomposition were profoundly increased by 24.62% 
and 156.28%, respectively in the Biofield Energy 
Treated sample compared to the control sample. The 
total weight loss was increased by 3.08% and the 
residue amount was reduced by 4.44% in the Biofield 
Energy Treated sample compared to the control sample. 
Overall, it is concluded that the Trivedi                            
Effect®-Consciousness Energy Healing Treatment might 
have generated a novel polymorph of silver sulfadiazine 
that may show better bioavailability in comparison to the 
control sample. Hence, the Consciousness Energy 
Healing Treated silver sulfadiazine would be more useful 
in designing the formulations with improved efficacy 
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Table 4. TGA/DTG data of the control and Biofield Energy Treated samples of silver sulfadiazine. 
Sample 
                                     TGA    DTG 
Total weight loss (%) Residue % Tmax (°C) 
Control 58.99 41.01 281.80 
Biofield Energy Treated 60.81 39.19 277.10 
% Change* 3.08 -4.44 -1.67 
*denotes the percentage change of the Biofield Energy Treated sample with respect to the control sample, 
Tmax = the temperature at which maximum weight loss takes place in TG or peak temperature in DTG. 
Sample Melting point (°C) ∆H(J/g) 
Decomposition     
temperature 
∆H(J/g) 
Control Sample 262.90 45.29 282.29 3.50 
Biofield Energy 
Treated 
262.55 56.44 277.64 8.97 
% Change* -0.13 24.62 -1.65 156.28 
Table 3. DSC data for both control and Biofield Energy Treated samples of silver sulfadiazine. 
ΔH: Latent heat of fusion/ decomposition,*denotes the percentage change of the Biofield Energy Treated 
sample with respect to the control sample. 
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Figure 2. DSC thermograms of the control and Biofield Energy Treated silver sulfadiazine. 
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Figure 3. TGA thermograms of the control and Biofield Energy Treated silver sulfadiazine. 
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Figure 4. DTG thermograms of the control and Biofield Energy Treated silver sulfadiazine 
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against burning infections. 
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